NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 5, 2025 $1.96 -2.70% $2.00 V 97.78% 1
Aug 5, 2025 $1.98 -1.69% $2.00 V 98.80% 2
Aug 5, 2025 $2.15 +6.97% $2.00 X 92.50% 0
Aug 5, 2025 Bullish $2.00 V 0
Aug 4, 2025 $1.98 +2.81% $2.01 V 98.72% 2
Aug 4, 2025 $1.96 +1.76% $2.01 V 97.71% 1
Aug 4, 2025 Bullish $2.01 V 1
Aug 4, 2025 $2.05 +6.22% $2.01 V 98.01% 1
Aug 1, 2025 $2.02 +2.84% $1.93 X 95.56% 0
Aug 1, 2025 $1.99 +1.78% $1.93 X 96.64% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE